XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Net sales $ 343,043 $ 256,426
Cost of sales 138,941 100,687
Gross margin 204,102 155,739
Operating expenses:    
Sales, general and administrative 116,567 90,129
Research and development 70,927 48,416
Total operating expenses 187,494 138,545
Income from operations 16,608 17,194
Interest and other income, net 25,276 55,299
Income before provision for income taxes 41,884 72,493
Provision for (benefit from) income taxes (3,255) 17,622
Net income $ 45,139 $ 54,871
Net income per common and common equivalent shares:    
Basic (in dollars per share) $ 0.62 $ 0.77
Diluted (in dollars per share) $ 0.61 $ 0.76
Weighted average number of common and common equivalent shares outstanding:    
Basic (in shares) 72,638 70,950
Diluted (in shares) 73,880 72,349
Net income $ 45,139 $ 54,871
Foreign currency translation adjustments 1,676 (1,072)
Unrealized gain (loss) on available-for-sale investments 184 (489)
Comprehensive income 46,999 53,310
Product    
Net sales 219,389 176,204
Cost of sales 107,584 79,352
Service    
Net sales 123,654 80,222
Cost of sales $ 31,357 $ 21,335